Related Experiment Video
Updated: Aug 11, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Hypothermia enhances protective effect of MK-801 against hypoxic/ischemic brain damage in infant rats
C Ikonomidou1, J L Mosinger, J W Olney
1Department of Psychiatry, Washington University Medical School, St. Louis, MO 63110.
Abstract:
Accumulating evidence suggests that the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor may play an important role in hypoxic/ischemic (H/I) brain damage. Accordingly, it has been shown that the NMDA antagonist, MK-801, partially protects the infant rat brain against H/I damage. Here we show that reducing the body temperature of the infant rat also confers partial protection against H/I brain damage and that mild hypothermia plus MK-801 treatment provides total protection against such damage. Relevance of these findings to the prevention of perinatal brain damage in humans is discussed.
Insights
Mild hypothermia and NMDA receptor antagonist MK-801 together completely protect infant rat brains from hypoxic/ischemic damage. This combination therapy offers a promising strategy for preventing brain injury in newborns.
Area of Science:
- Neuroscience
- Neonatal research
- Neuroprotection
Background:
- Glutamate receptor overactivation contributes to hypoxic/ischemic (H/I) brain damage.
- N-methyl-D-aspartate (NMDA) receptors are implicated in H/I injury.
- NMDA antagonists like MK-801 show partial neuroprotective effects.
Purpose of the Study:
- To investigate the combined neuroprotective effects of hypothermia and NMDA receptor antagonism.
- To evaluate the efficacy of mild hypothermia and MK-801 in preventing H/I brain damage in infant rats.
Main Methods:
- Infant rats were subjected to hypoxic/ischemic (H/I) conditions.
- Treatment groups included MK-801 administration, mild hypothermia, and a combination of both.
- Brain damage was assessed following H/I insult.
Main Results:
- Mild hypothermia alone provided partial protection against H/I brain damage.
- MK-801 treatment also conferred partial protection.
- The combination of mild hypothermia and MK-801 resulted in total protection against H/I brain damage.
Conclusions:
- Combined mild hypothermia and NMDA receptor blockade offer synergistic neuroprotection.
- This therapeutic strategy holds potential for preventing perinatal brain injury in humans.
- Further research is warranted to translate these findings to clinical practice.
